- Home
- XP vs CAI Comparison
XP vs CAI Comparison
Compare XP & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XP
- CAI
- Stock Information
- Founded
- XP 2001
- CAI 2008
- Country
- XP Cayman Islands
- CAI United States
- Employees
- XP N/A
- CAI N/A
- Industry
- XP Investment Bankers/Brokers/Service
- CAI Medical Specialities
- Sector
- XP Finance
- CAI Health Care
- Exchange
- XP Nasdaq
- CAI Nasdaq
- Market Cap
- XP 8.6B
- CAI 8.6B
- IPO Year
- XP 2019
- CAI 2025
- Fundamental
- Price
- XP $15.99
- CAI $30.22
- Analyst Decision
- XP Strong Buy
- CAI Strong Buy
- Analyst Count
- XP 6
- CAI 6
- Target Price
- XP $23.67
- CAI $35.50
- AVG Volume (30 Days)
- XP 7.2M
- CAI 823.8K
- Earning Date
- XP 11-18-2025
- CAI 11-12-2025
- Dividend Yield
- XP 8.64%
- CAI N/A
- EPS Growth
- XP 18.07
- CAI N/A
- EPS
- XP 1.67
- CAI N/A
- Revenue
- XP $3,085,301,717.00
- CAI $533,847,000.00
- Revenue This Year
- XP $17.02
- CAI $64.66
- Revenue Next Year
- XP $12.40
- CAI $45.81
- P/E Ratio
- XP $9.46
- CAI N/A
- Revenue Growth
- XP 6.65
- CAI 106.53
- 52 Week Low
- XP $10.82
- CAI $25.40
- 52 Week High
- XP $20.64
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- XP 31.45
- CAI N/A
- Support Level
- XP $15.77
- CAI N/A
- Resistance Level
- XP $16.46
- CAI N/A
- Average True Range (ATR)
- XP 0.59
- CAI 0.00
- MACD
- XP -0.36
- CAI 0.00
- Stochastic Oscillator
- XP 6.16
- CAI 0.00
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.